1. ホーム
  2. 一覧
論文 特許

論文 - 一覧

  • 14 Hits
  • 検索条件 : 絞込み (MeSH = Niacinamide / analogs & derivatives*)
生物種 リソース名 タイトル
ヒト・動物細胞 KP4(RCB1005) LY2801653 is an orally bioavailable multi-kinase inhibitor with potent activity against MET, MST1R, and other oncoproteins, and displays anti-tumor activities in mouse xenograft models.
ヒト・動物細胞 Hep G2 Activated p53 with Histone Deacetylase Inhibitor Enhances L-Fucose-Mediated Drug Delivery through Induction of Fucosyltransferase 8 Expression in Hepatocellular Carcinoma Cells.
ヒト・動物細胞 NB1RGB(RCB0222) Analysis of structural features of bis-quaternary ammonium antimicrobial agents 4,4'-(alpha,omega-polymethylenedithio)bis (1-alkylpyridinium iodide)s using computational simulation.
ヒト・動物細胞 LNCap.FGC(RCB2144) Impact of 18F-PSMA-1007 Uptake in Prostate Cancer Using Different Peptide Concentrations: Preclinical PET/CT Study on Mice.
メダカ fli1::GFP (TG1206) , Kyoto-Cab Effect of histidine on sorafenib-induced vascular damage: Analysis using novel medaka fish model.
ヒト・動物細胞 RBE(RCB1292) , YSCCC(RCB1549) Survival pathway of cholangiocarcinoma via AKT/mTOR signaling to escape RAF/MEK/ERK pathway inhibition by sorafenib.
ヒト・動物細胞 Hep G2(RCB1886) , PK-1(RCB1972) , KLM-1(RCB2138) Questiomycin A stimulates sorafenib-induced cell death via suppression of glucose-regulated protein 78.
ヒト・動物細胞 HuCCT1(RCB1960) Gemcitabine and Oxaliplatin, but Not Sorafenib or Paclitaxel, Have a Synergistic Effect with Yttrium-90 in Reducing Hepatocellular Carcinoma and Cholangiocarcinoma Cell Line Viability.
ヒト・動物細胞 HuH-7 Metformin inhibits the invasion of human hepatocellular carcinoma cells and enhances the chemosensitivity to sorafenib through a downregulation of the ERK/JNK-mediated NF-κB-dependent pathway that reduces uPA and MMP-9 expression.
ヒト・動物細胞 GSU(RCB2278) , Kato III(RCB2088) , KE-97(RCB1435) , MKN45(RCB1001) , NUGC-4(RCB1939) A novel inhibitor of c-Met and VEGF receptor tyrosine kinases with a broad spectrum of in vivo antitumor activities.
ヒト・動物細胞 Hep G2 , HuH-7 Sorafenib and TRAIL have synergistic effect on hepatocellular carcinoma.
ヒト・動物細胞 HuH-7 Wnt-pathway activation in two molecular classes of hepatocellular carcinoma and experimental modulation by sorafenib.
ヒト・動物細胞 HuH-7 Improving Drug Penetrability with iRGD Leverages the Therapeutic Response to Sorafenib and Doxorubicin in Hepatocellular Carcinoma.
ヒト・動物細胞 HL60(RCB0041) Expression of CD38 in human promyelocytic leukemia HL-60 cell line during differentiation by niacin-related compounds.